USPTO serial 79261911
BYME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 7, 2020
- Examiner
- BRADLEY, EVELYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BYME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy C. Ziegler
Amy C. Ziegler GREER, BURNS & CRAIN, LTD.200 W. Madison St.Suite 2100CHICAGO, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | sexual activity apparatus, devices and articles, namely, condoms for medical purposes; vaginal dilators for women, vacuum therapy devices; surgical, medical, dental and veterinary apparatus and instruments, namely, for blood sampling, lancets for blood sampling; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic belts, orthopedic cast padding, orthopedic footwear, orthopedic hip prostheses, orthopedic inserts for footwear; suture materials; syringes for medical purposes, namely, safety syringes; lancets; medical lancing devices; medical lancing devices, namely, single use lancing devices; blood lancets; disposable lancets for finger puncture; blood testing apparatus; diagnostic apparatus for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing, medical diagnostic apparatus for testing for HIV, namely, HIV testing kits comprised of lancets, blood collection needles, and test strips; needles for medical purposes; needles for injections, namely, pen needles; needles for injections, namely, safety pen needles; suture needles; hypodermic needles; medical syringes; injection syringes; syringes for medical purposes and for injections, namely, auto-injector medical syringes; syringes for medical purposes and for injections, namely, medical syringe needles; needles for injections; needles for surgical purposes; needles for medical purposes, namely, disposable needles for finger puncture; surgical cutlery; eye droppers; gynecological dilators, namely, vaginal dilators; medical devices for gynecological treatment, namely, gynecological medical instruments for examining women's reproductive organs; medical devices for treating erectile dysfunction, namely, pumps for medical purposes, constriction rings for use in maintaining penile rigidity in men with erectile dysfunction; blood testing equipment, namely, blood collecting tubes, medical equipment for sampling and analyzing blood and body tissue; medical devices for diabetes care, eye care, sexual health, blood sampling, injection, neuropathy, rapid diagnostic testing, point of care testing; tools for medical diagnostics, namely, blood sampling lancets; testing probes for medical purposes; medical instruments for application on human bodies, namely, blood sampling lancets; medical testing instruments, namely, apparatus for medical diagnostic testing in the field of diabetes, sexual health care, blood sampling; diagnostic apparatus for pregnancy testing, namely, ultrasound diagnostic apparatus; medical instruments for testing HIV, namely, blood testing apparatus; testing instruments for medical diagnostic purposes, namely, lancets for blood sampling; urine testing instruments for medical diagnostic purposes, namely, medical specimen collection devices in the nature of cups for the collection of urine; diagnostic testing apparatus for use in immunoassay procedures being medical, namely, apparatus used in implementing diagnosis tests designed to detect infectious diseases; apparatus for DNA and RNA testing for medical purposes; blood pressure testing apparatus, namely, blood pressure monitors; medical instruments, namely, biosensors for detecting infectious diseases; diagnostic, examination, and monitoring equipment for medical purposes, namely, medical examination gloves, blood sampling materials, disposable lancets for finger puncture, blood testing apparatus, namely, test strips and test tubes for measuring blood glucose levels; diagnostic measuring apparatus for medical use; electric instruments for medical use in the diagnosis of blood; genetic testing apparatus for medical purposes; medical specimen collection devices in the nature of glasses for the collection of urine; replacement parts and fittings for all the aforesaid goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Owen Mumford Limited
- Other trademarks owned by Owen Mumford Limited
- Other trademarks owned by Owen Mumford Limited
- Other trademarks owned by Owen Mumford Limited
- Other trademarks in Class 010
- Similar marks named BYME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 14, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 2, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 7, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 24, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 24, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 24, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 21, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 2, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 2, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 7, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 19, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 20, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 20, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 15, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 15, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 30, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 29, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 15, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 4, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |